Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel and targeted therapies for challenging oncology indications. The company is leveraging its deep expertise in drug development to advance a pipeline of proprietary therapeutics designed to overcome limitations of existing treatments and improve outcomes for cancer patients. Their strategy involves identifying and acquiring promising drug candidates and rapidly advancing them through clinical development.
Serves as the company's principal executive office, housing key leadership, strategic planning, financial operations, and corporate governance functions.
Located in the Hudson Square neighborhood, a dynamic area known for its mix of modern and historic commercial buildings. The office provides a professional environment for its executive and corporate teams.
Nuvation Bio's New York headquarters likely fosters a high-performance, agile, and collaborative work culture. Given its mission-driven focus in oncology, the environment emphasizes innovation, scientific excellence, and a sense of urgency to bring new therapies to patients.
The New York headquarters is central to Nuvation Bio's strategic decision-making, investor relations, and overall corporate direction. Its location in a major global financial and business hub facilitates access to capital, talent, and industry partnerships.
Nuvation Bio's core operations, including executive leadership and research facilities, are primarily based in the United States (New York and San Francisco). While they may not have a widespread network of international offices, their clinical development programs for cancer therapies often involve collaboration with clinical trial sites and investigators globally to ensure diverse patient populations and efficient trial execution. Their business development and partnering activities may also have an international reach.
180 Varick Street, Suite 806
New York
NY
USA
Address: 101 Second Street, Suite 2525, San Francisco, CA 94105
To leverage the extensive network of research institutions, scientific talent, and specialized services available in one of the world's leading biotechnology clusters, facilitating drug discovery and development efforts.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Nuvation Bio' leadership includes:
Nuvation Bio has been backed by several prominent investors over the years, including:
In the past year (May 2023 - May 2024), Nuvation Bio strengthened its executive leadership by appointing a new Chief Technical Operations Officer to oversee manufacturing and supply chain. No major executive departures were publicly announced during this period.
Discover the tools Nuvation Bio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Nuvation Bio likely utilizes a common corporate email format, typically combining an employee's first initial and last name, or first name and last name separated by a period, with the company domain.
[first_initial][last]@nuvationbio.com
Format
jdoe@nuvationbio.com
Example
75%
Success rate
Business Wire • May 9, 2024
Nuvation Bio announced its financial results for the first quarter ended March 31, 2024, and provided updates on its clinical programs, including NUV-868 and NUV-1511, and other corporate developments....more
Business Wire • February 27, 2024
The company reported its financial results for the fourth quarter and full year ended December 31, 2023, highlighting progress in its oncology pipeline and outlining its strategic priorities for the upcoming year....more
Business Wire • July 10, 2023
Nuvation Bio announced the appointment of David C. Hanley, Ph.D., as its Chief Technical Operations Officer, responsible for leading all aspects of chemistry, manufacturing, and controls (CMC) and supply chain operations....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Nuvation Bio, are just a search away.